Key facts
- Notable investors include Nanjing New Industry Investment Group, New Film Private Equity Fund Management, Zhilai Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Renocell Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Renocell Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Renocell Biotech
Researcher and manufacturer of drugs intended to serve the pharmaceutical industry. The company is mainly focused on the research and development of stem cell therapy, providing clients with industry-leading standard drug products.
- Sector
- Healthcare
- HQ
- Nanjing, China
- Founded
- 2020
- Website
- rybiotech.cn/
- Ownership
- Privately Held (backing)
Renocell Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Renocell Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Renocell Biotech in its N-PORT filings yet. We sweep new filings monthly.